These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20658169)

  • 1. Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.
    Tippayamontri T; Kotb R; Paquette B; Sanche L
    Invest New Drugs; 2011 Dec; 29(6):1321-7. PubMed ID: 20658169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model.
    Tippayamontri T; Kotb R; Paquette B; Sanche L
    Anticancer Res; 2012 Oct; 32(10):4395-404. PubMed ID: 23060564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic possibilities of combined treatment of radiotherapy with oxaliplatin and its liposomal formulation, Lipoxal™, in rectal cancer using xenograft in nude mice.
    Tippayamontri T; Kotb R; Sanche L; Paquette B
    Anticancer Res; 2014 Oct; 34(10):5303-12. PubMed ID: 25275023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
    Tippayamontri T; Kotb R; Paquette B; Sanche L
    Anticancer Res; 2013 Aug; 33(8):3005-14. PubMed ID: 23898053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
    Shi M; Fortin D; Paquette B; Sanche L
    Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.
    Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
    J Neurooncol; 2013 Dec; 115(3):365-73. PubMed ID: 24026531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
    Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
    Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.
    Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):244-9. PubMed ID: 22284691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.
    Virag P; Perde-Schrepler M; Fischer-Fodor E; Tatomir C; Dorneanu SA; Cernea VI; Irimie A
    Anticancer Drugs; 2012 Nov; 23(10):1032-8. PubMed ID: 22614106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.
    Hellberg V; Wallin I; Eriksson S; Hernlund E; Jerremalm E; Berndtsson M; Eksborg S; Arnér ES; Shoshan M; Ehrsson H; Laurell G
    J Natl Cancer Inst; 2009 Jan; 101(1):37-47. PubMed ID: 19116379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.
    Fedier A; Poyet C; Perucchini D; Boulikas T; Fink D
    Anticancer Drugs; 2006 Mar; 17(3):315-23. PubMed ID: 16520660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
    Hata T; Yamamoto H; Ngan CY; Koi M; Takagi A; Damdinsuren B; Yasui M; Fujie Y; Matsuzaki T; Hemmi H; Xu X; Kitani K; Seki Y; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Mol Cancer Ther; 2005 Oct; 4(10):1585-94. PubMed ID: 16227409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
    Ekblad L; Kjellström J; Johnsson A
    Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K; Kato N; Takagi A; Koi M; Hemmi H
    Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.
    Huo T; Barth RF; Yang W; Nakkula RJ; Koynova R; Tenchov B; Chaudhury AR; Agius L; Boulikas T; Elleaume H; Lee RJ
    PLoS One; 2012; 7(11):e48752. PubMed ID: 23152799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.
    Wang S; Zhang H; Scharadin TM; Zimmermann M; Hu B; Pan AW; Vinall R; Lin TY; Cimino G; Chain P; Vuyisich M; Gleasner C; Mcmurry K; Malfatti M; Turteltaub K; de Vere White R; Pan CX; Henderson PT
    PLoS One; 2016; 11(1):e0146256. PubMed ID: 26799320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
    Meynard D; Le Morvan V; Bonnet J; Robert J
    Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.
    Nguyen TT; Ostergaard J; Stürup S; Gammelgaard B
    Int J Pharm; 2013 Jun; 449(1-2):95-102. PubMed ID: 23583709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.